Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease

Renal osteodystrophy is common in patients with chronic kidney disease and end-stage renal disease and leads to the risks of fracture and extraosseous vascular calcification. Secondary hyperparathyroidism (SHPT) is characterized by a compensatory increase in parathyroid hormone (PTH) secretion in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yi-Chou, Zheng, Cai-Mei, Chiu, Hui-Wen, Liu, Wen-Chih, Lu, Kuo-Cheng, Lu, Chien-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415417/
https://www.ncbi.nlm.nih.gov/pubmed/36015101
http://dx.doi.org/10.3390/ph15080952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415417/
https://www.ncbi.nlm.nih.gov/pubmed/36015101
http://dx.doi.org/10.3390/ph15080952

Ejemplares similares